Conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and Hashimotos thyroiditis are common examples
Hinke SA, Gelling RW, Pederson RA, et al
Clinical trials for Zepbound showed that participants achieved an average weight loss of 15% to 22.5%, depending on dosage, with results tracked over 72 weeks under controlled conditions
Booth is a nurse practitioner at Primary Health Network, a federally qualified health center in Pennsylvania
This case is notable because the patient had previously tolerated dulaglutide without any injection site reactions, emphasizing that tolerance to one GLP-1 agonist does not predict tolerance to another
What are the disadvantages of choosing white-label GLP-1 supplements